Eric Easom is the founder of AN2 Therapeutics. AN2 Therapeutics has raised $161M in total funding. Latest round: IPO. Based in Menlo Park, California, US.
Eric Easom is the Co-Founder, President, and CEO of AN2 Therapeutics, a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases. He founded the company in Menlo Park, California in 2017.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide